- Home
- News
- latamerica
- pathology molecular
Refine by
Pathology Molecular Articles & Analysis
14 news found
The addition of these new applications will help us gain a better understanding of what drives cancers down to a molecular level,” said Thomas Stricker, MD, PhD, Pathology Lab Director, Center for Molecular and Genomic Studies, Tennessee Oncology. ...
The incidence of landscape fires has been rising globally, leading to increased exposure to landscape fire smoke (LFS) among millions of people. The inhalation of particulate matter (PM) from LFS is associated with adverse respiratory and cardiovascular outcomes. However, the mechanisms by which LFS impacts these functions remain inadequately understood. This blog focuses on a new ...
(“Interpace” or the “Company”) (OTCQX: IDXG), a fully integrated commercial company that provides clinically relevant molecular diagnostic tests and pathology services for improved patient diagnosis and management, today announced new clinical validation data for their thyroid cancer test platform which is comprised of a mutation panel ...
Molecular Health, an international biotech IT company based in Heidelberg, Germany, has received European Union certification for its MH Guide clinical decision support software (SaaS) under the new In Vitro Diagnostics Regulation (EU) 2017/746 (IVDR). The MH Guide software, which is used in molecular pathology laboratories, is the first of its ...
He holds joint appointments in the departments of investigational cancer therapeutics (phase I program) and translational molecular pathology. Dr. Tang is a board-certified radiation oncologist who received his MD from Stanford University and underwent residency training in radiation oncology at MD Anderson Cancer Center. ...
ByCervoMed
Molecular Health has launched the latest version of its analysis software MH Guide. This software, which is used by pathology laboratories and molecular tumor boards, now has improved search capabilities to identify patient- relevant clinical studies. ...
Oermann is working to expand the Department of Pathology’s molecular diagnostic capacity. Building on intraoperative data gathered using stimulated Raman histology (SRH)—the laser-based imaging technique pioneered by Dr. ...
“We previously hypothesized that more aggressive molecular subtypes might be detectable based on their OA/US feature scores. ...
The instrument enables researchers to uncover unique molecular signatures that may be obscured in heterogeneous tumor samples. ...
One of the first commercially available high-sensitivity target-enrichment technologies for next-generation sequencing, HaloPlexHS incorporates more than 1 million unique molecular barcodes for accurate detection of alleles at low frequencies. The molecular barcodes are especially important for cancer researchers who work with heterogeneous samples in which ...
(NYSE: A) today announced that Carlos Cordon-Cardo, M.D., Ph.D., of the Mount Sinai Health System, has received an Agilent Thought Leader Award in recognition of his groundbreaking work in molecular and translational pathology. Dr. Cordon-Cardo is the Irene Heinz Given and John LaPorte Given Professor and chair of Pathology at Mount Sinai. ...
"We are extremely excited by these data linking INT41 results to specific molecular events in Huntington's pathology. INT41 provides a surgical approach to inactivate the event for which a growing body of evidence indicates occurs prior to symptoms and may be the driver of disease progression" said Lee Henderson, Ph.D., the CEO of Vybion and a coauthor on the ...
ByVybion
(NYSE: A) today introduced Agilent SureFISH probes, the next generation of fluorescent in situ hybridization (FISH) assays, delivering a comprehensive menu of the industry's highest resolution probes for a wide range of molecular analysis applications. Agilent SureFISH probes deliver dramatically better performance compared to existing FISH products. ...
The fund will target three broad areas for investment: Broad-based Diagnostics, including imaging, home health, patient monitoring, molecular diagnostics, pathology, novel imaging agents and other technologies for disease diagnosis. ...